Perrigo (PRGO) Operating Expenses (2012 - 2026)
Perrigo's (PRGO) quarterly Operating Expenses came in at $697.8 million in Q1 2026, up 102.03% year-on-year from $345.4 million in Q1 2025, and down 57.69% on a QoQ basis from $1.6 billion in Q4 2025.
Perrigo (PRGO) Operating Expenses (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Operating Expenses data on file, last reported at $697.8 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 102.03% year-over-year to $697.8 million in Q1 2026; TTM through Mar 2026 was $3.0 billion, a 117.95% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 83.01% from the prior year.
- Operating Expenses for Q1 2026 stood at $697.8 million, down from $1.6 billion in the prior quarter.
- Over the last five years, Operating Expenses for PRGO reached as high as $1.6 billion in Q4 2025 and fell as low as $271.7 million in Q4 2024.
- Historically, Operating Expenses has averaged $450.0 million across 5 years, with a median of $351.6 million in 2022.
- Across the five-year window, Operating Expenses slumped 38.65% in 2024 and surged 507.03% in 2025, its largest moves.
- Year by year, Operating Expenses stood at $351.6 million in 2022, then advanced by 25.97% to $442.9 million in 2023, then slumped by 38.65% to $271.7 million in 2024, then jumped by 507.03% to $1.6 billion in 2025, then slumped by 57.69% to $697.8 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $697.8 million in Q1 2026, $1.6 billion in Q4 2025, and $304.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.04 Bn | 325.50 Mn | 697.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 697.80 Mn |
| Dec 31, 2025 | 1.65 Bn |
| Sep 27, 2025 | 304.50 Mn |
| Jun 28, 2025 | 317.50 Mn |
| Mar 29, 2025 | 345.40 Mn |
| Dec 31, 2024 | 271.70 Mn |
| Sep 28, 2024 | 324.00 Mn |
| Jun 29, 2024 | 421.20 Mn |
| Mar 30, 2024 | 412.90 Mn |
| Dec 31, 2023 | 442.90 Mn |
| Sep 30, 2023 | 349.10 Mn |
| Jul 1, 2023 | 371.20 Mn |
| Apr 1, 2023 | 365.30 Mn |
| Dec 31, 2022 | 351.60 Mn |
| Oct 1, 2022 | 329.80 Mn |
| Jul 2, 2022 | 379.00 Mn |
| Apr 2, 2022 | 316.10 Mn |
| Dec 31, 2021 | 315.70 Mn |
| Oct 2, 2021 | -101.90 Mn |
| Jul 3, 2021 | 474.90 Mn |